BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27389698)

  • 1. Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease.
    Vazzana N; Santilli F; Lattanzio S; Liani M; Giacci L; Del Rosso G; Salvati F; Boccatonda A; Ferroni P; Davì G
    Eur J Intern Med; 2016 Sep; 33():74-80. PubMed ID: 27389698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous secretory RAGE in obese women: association with platelet activation and oxidative stress.
    Vazzana N; Guagnano MT; Cuccurullo C; Ferrante E; Lattanzio S; Liani R; Romano M; Davì G
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1726-30. PubMed ID: 22761461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C→T polymorphism.
    Dragani A; Falco A; Santilli F; Basili S; Rolandi G; Cerasa L; Lattanzio S; Ciabattoni G; Patrono C; Davì G
    Thromb Haemost; 2012 Sep; 108(3):533-42. PubMed ID: 22782530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress.
    Ferrante E; Vazzana N; Santilli F; Di Cicco M; Lauriti C; Di Battista L; Ciabattoni G; Di Matteo L; Davì G
    Free Radic Biol Med; 2010 Sep; 49(5):857-64. PubMed ID: 20541603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced lipid peroxidation and platelet activation as potential contributors to increased cardiovascular risk in the low-HDL phenotype.
    Vazzana N; Ganci A; Cefalù AB; Lattanzio S; Noto D; Santoro N; Saggini R; Puccetti L; Averna M; Davì G
    J Am Heart Assoc; 2013 Apr; 2(2):e000063. PubMed ID: 23557750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus.
    Santilli F; Davì G; Consoli A; Cipollone F; Mezzetti A; Falco A; Taraborelli T; Devangelio E; Ciabattoni G; Basili S; Patrono C
    J Am Coll Cardiol; 2006 Jan; 47(2):391-7. PubMed ID: 16412866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation.
    Davì G; Neri M; Falco A; Festi D; Taraborelli T; Ciabattoni G; Basili S; Cuccurullo F; Patrono C
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):246-51. PubMed ID: 15472127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration.
    Davì G; Chiarelli F; Santilli F; Pomilio M; Vigneri S; Falco A; Basili S; Ciabattoni G; Patrono C
    Circulation; 2003 Jul; 107(25):3199-203. PubMed ID: 12810609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet activation in obese women: role of inflammation and oxidant stress.
    Davì G; Guagnano MT; Ciabattoni G; Basili S; Falco A; Marinopiccoli M; Nutini M; Sensi S; Patrono C
    JAMA; 2002 Oct 23-30; 288(16):2008-14. PubMed ID: 12387653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of platelet activation in human essential hypertension.
    Minuz P; Patrignani P; Gaino S; Seta F; Capone ML; Tacconelli S; Degan M; Faccini G; Fornasiero A; Talamini G; Tommasoli R; Arosio E; Santonastaso CL; Lechi A; Patrono C
    Hypertension; 2004 Jan; 43(1):64-70. PubMed ID: 14656953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease.
    Minuz P; Patrignani P; Gaino S; Degan M; Menapace L; Tommasoli R; Seta F; Capone ML; Tacconelli S; Palatresi S; Bencini C; Del Vecchio C; Mansueto G; Arosio E; Santonastaso CL; Lechi A; Morganti A; Patrono C
    Circulation; 2002 Nov; 106(22):2800-5. PubMed ID: 12451006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype-independent in vivo oxidative stress following a methionine loading test: maximal platelet activation in subjects with early-onset thrombosis.
    Di Minno MN; Pezzullo S; Palmieri V; Coppola A; D'Angelo A; Sampietro F; Cavalca V; Tremoli E; Di Minno G
    Thromb Res; 2011 Oct; 128(4):e43-8. PubMed ID: 21669453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost.
    Lessiani G; Vazzana N; Cuccurullo C; Di Michele D; Laurora G; Sgrò G; Di Ruscio P; Simeone E; Di Iorio P; Lattanzio S; Liani R; Ferrante E; Davì G
    Thromb Haemost; 2011 Feb; 105(2):321-8. PubMed ID: 21103664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of platelet activation in Alzheimer's disease.
    Ciabattoni G; Porreca E; Di Febbo C; Di Iorio A; Paganelli R; Bucciarelli T; Pescara L; Del Re L; Giusti C; Falco A; Sau A; Patrono C; Davì G
    Neurobiol Aging; 2007 Mar; 28(3):336-42. PubMed ID: 16442186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of vitamin E supplementation on F(2)-isoprostane and thromboxane biosynthesis in healthy cigarette smokers.
    Patrignani P; Panara MR; Tacconelli S; Seta F; Bucciarelli T; Ciabattoni G; Alessandrini P; Mezzetti A; Santini G; Sciulli MG; Cipollone F; Davì G; Gallina P; Bon GB; Patrono C
    Circulation; 2000 Aug; 102(5):539-45. PubMed ID: 10920066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus.
    Santilli F; Formoso G; Sbraccia P; Averna M; Miccoli R; Di Fulvio P; Ganci A; Pulizzi N; Lattanzio S; Ciabattoni G; Consoli A; Lauro R; Patrono C; Davì G
    J Thromb Haemost; 2010 Apr; 8(4):828-37. PubMed ID: 20088941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidant stress as a major determinant of platelet activation in invasive breast cancer.
    Ferroni P; Santilli F; Cavaliere F; Simeone P; Costarelli L; Liani R; Tripaldi R; Riondino S; Roselli M; Davi G; Guadagni F
    Int J Cancer; 2017 Feb; 140(3):696-704. PubMed ID: 27784132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress and platelet activation in homozygous homocystinuria.
    Davì G; Di Minno G; Coppola A; Andria G; Cerbone AM; Madonna P; Tufano A; Falco A; Marchesani P; Ciabattoni G; Patrono C
    Circulation; 2001 Sep; 104(10):1124-8. PubMed ID: 11535567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mediterranean diet reduces thromboxane A2 production in atrial fibrillation patients.
    Pignatelli P; Pastori D; Farcomeni A; Nocella C; Bartimoccia S; Vicario T; Bucci T; Carnevale R; Violi F
    Clin Nutr; 2015 Oct; 34(5):899-903. PubMed ID: 25288566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboxane-Dependent Platelet Activation in Obese Subjects with Prediabetes or Early Type 2 Diabetes: Effects of Liraglutide- or Lifestyle Changes-Induced Weight Loss.
    Simeone P; Liani R; Tripaldi R; Di Castelnuovo A; Guagnano MT; Tartaro A; Bonadonna RC; Federico V; Cipollone F; Consoli A; Santilli F
    Nutrients; 2018 Dec; 10(12):. PubMed ID: 30513818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.